Facebook
Twitter
Telegram
Report an ErrorCatalyst Pharmaceuticals Cash Flow 2011-2024 | CPRX
Annual Cash Flow Catalyst Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
144 M | 116 M | 60.4 M | 45 M | 34.6 M | -26.1 M | -13.7 M | - | - | - | -9.88 M | -5.14 M | -4.99 M |
Depreciation & Amortization |
316 K | 141 K | 192 K | 92 K | 55 K | 38 K | 45.7 K | 43.4 K | 34.5 K | 26.6 K | 22.5 K | 10.9 K | 42.8 K |
Accounts Payables |
14.8 M | 3.98 M | 2.77 M | 4.26 M | 4.12 M | 2.34 M | 1.95 M | 933 K | 1.79 M | 1.81 M | 851 K | 1.37 M | 264 K |
Accounts Receivables |
53.5 M | 10.4 M | 6.62 M | 5.99 M | 10.5 M | - | - | - | - | - | - | - | - |
Total Inventories |
15.6 M | 6.8 M | 7.87 M | 4.65 M | 1.96 M | 56 K | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Catalyst Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
31.9 M | - | - | - | 12.1 M | - | 76 M | 34.7 M | 8.48 M | - | 41.2 M | 19.5 M | 3.81 M | - | 31.9 M | 20.5 M | 7.21 M | - | 22.3 M | 6.06 M | -8.02 M | - | -17.8 M | -10.8 M | -6.08 M | - | -9.71 M | -7.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.25 M | - | -3.55 M | -2.45 M | -1.3 M | - | -3.55 M | -2.29 M | -831 K |
Depreciation & Amortization |
86 K | - | - | - | 69 K | - | 106 K | 71 K | 34 K | - | 159 K | 128 K | 97 K | - | 73 K | 43 K | 14 K | - | 6.53 K | 20.2 K | 13.7 K | - | 9.29 K | 8.18 K | 8.02 K | - | 12.8 K | 13 K | 13 K | - | 9.48 K | 8.76 K | 13.2 K | - | 11.3 K | 8.98 K | 8.15 K | - | 7.24 K | 6.08 K | 5.28 K | - | 5.71 K | 5.71 K | 5.36 K | - | 8.24 K | 5.51 K | 2.8 K | - | 7.45 K | 21 K | 6.44 K |
Accounts Payables |
10.3 M | 14.8 M | 4.6 M | 4.42 M | 3.39 M | 3.98 M | 2.53 M | 2.32 M | 5.14 M | 2.77 M | 2.75 M | 2.92 M | 2.56 M | 4.26 M | 4.26 M | 4.26 M | 4.26 M | 4.12 M | 4.12 M | 4.12 M | 4.12 M | 2.34 M | 2.34 M | 2.34 M | 2.34 M | 1.95 M | 1.95 M | 1.95 M | 1.95 M | 933 K | 933 K | 933 K | 933 K | 1.79 M | 1.79 M | 1.79 M | 1.79 M | 1.81 M | 1.81 M | 1.81 M | 1.81 M | 851 K | 851 K | 851 K | 851 K | 1.37 M | 1.37 M | 1.37 M | 1.37 M | 264 K | 264 K | 264 K | 264 K |
Accounts Receivables |
60.5 M | 53.5 M | 48 M | 42.8 M | 33.4 M | 10.4 M | 9.34 M | 9.59 M | 10.6 M | 6.62 M | 6.62 M | 6.29 M | 5.6 M | 5.99 M | 5.99 M | 5.99 M | 5.99 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
20 M | 15.6 M | 9.04 M | 10.8 M | 10.3 M | 6.8 M | 7.13 M | 7.85 M | 7.83 M | 7.87 M | 6.95 M | 7.1 M | 4.39 M | 4.65 M | 4.65 M | 4.65 M | 4.65 M | 1.96 M | 1.96 M | 1.96 M | 1.96 M | 56 K | 56 K | 56 K | 56 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency